openPR Logo
Press release

Recombinant DNA Technology Market to Surpass US$ 196.7 Billion by 2026

08-07-2018 04:21 PM CET | Health & Medicine

Press release from: CMI Research

Recombinant DNA Technology Market to Surpass US$ 196.7 Billion

Global Recombinant DNA Technology Market, by Product Type (Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy, and Gene Editing), by Application (Therapeutics, Agriculture, and Research), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 106.8 Billion in 2017 and is projected to exhibit a CAGR of 7.9% over the forecast period (2017 – 2025), as highlighted in a new report published by Coherent Market Insights. The recombinant DNA technology market is expected to gain significant traction, owing to the availability of a broad range of approved recombinant therapeutics, presence of novel rDNA based gene editing systems in the clinical trials, and higher number of CAR-T gene therapies in the developmental pipeline over the forecast period.

Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/893

Increasing number of approvals from regulatory agencies for novel recombinant DNA based therapies to augment market growth

Recombinant DNA technology has multidisciplinary applications which deals with important aspects of life such as health improvement and food enrichment. Various novel recombinant products have been approved by the regulatory agencies favoring the rapid launch and availability of innovative therapeutics, thus bolstering the market growth. Recombinant DNA technology has played a vital role in improving health conditions for patients diagnosed with asthma, hemophilia, and cancer by developing new vaccines and pharmaceuticals For instance, in 2015, the FDA approved Nucala (mepolizumab) made by GlaxoSmithKline Plc., a humanized interleukin-5 antagonist monoclonal antibody produced by recombinant DNA technology in Chinese hamster ovary cells, to treat severe asthma, thus providing a therapeutic boon to address the rising patient pool. According to the Centers for Disease Control and Prevention (CDC), 2013, more than 22 million people in the U.S. have asthma, and there are more than 400,000 asthma-related hospitalizations annually. Also, in 2016, CSL Behring received FDA approval for Idelvion, Coagulation Factor IX, albumin fusion protein produced by recombinant DNA technology, for use in children and adults with Hemophilia B.

Moreover, the application of this technology in the field of gene therapy has advanced the therapeutic potential targeting the life threatening diseases. For instance, in 2017, Novartis AG received FDA approval for Kymriah (tisagenlecleucel), the first chimeric antigen receptor T cell (CAR-T) therapy, indicated for the treatment of acute lymphoblastic leukemia (ALL).

Browse 38 Market Data Tables and 26 Figures spread through 183 Pages and in-depth TOC on “Recombinant DNA Technology Market”- Global Forecast to 2025, by Product Type (Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy and Gene Editing), by Application (Therapeutics, Agriculture and Research), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/893

Manufacturers and biotechnology institutes are undertaking research activities to explore and launch novel therapies based on the gene editing systems to treat sickle cell anemia and cancer, thus favoring the market growth. For instance, in 2016, the Columbia University Medical Center (CUMC) and University of Iowa scientists used CRISPR to repair a genetic mutation responsible for retinitis pigmentosa (RP), an inherited condition that causes the retina to degrade and leads to blindness in at least 1.5 million cases worldwide. In January 2018, researchers from University of Pennsylvania were involved in CRISPR based therapy on cancer and have received approval to conduct the first CRISPR trial treating human patients in the U.S. from the National Institutes of Health and the FDA to treat melanoma, sarcoma, and multiple myeloma.

Key Takeaways of the Recombinant DNA Technology Market:

The global recombinant DNA technology market is expected to exhibit a CAGR of 7.9% over the forecast period, owing to the robust presence of pipeline products, major research activities undertaken for the novel gene editing systems such as CRISPR and its higher potential in disease treatment

Among product type, recombinant therapeutic proteins segment holds a dominant position in the recombinant DNA technology market, owing to the vast category of products available for treating various indications such as diabetes, cancer, hemophilia, and asthma

Among application, therapeutics segment holds a dominant position in the recombinant DNA technology market, owing to rising number of genetically engineered products such as recombinant insulin, erythropoietin, and novel gene therapies to treat various human diseases

Some of the major players operating in the global recombinant DNA technology market are Thermo Fisher Scientific, Inc., Biogen, Inc., Sanofi Pasteur, Merck & Co., Inc., Pfizer, Inc., Profacgen, Amgen, Inc., and Monsanto Company

To know the latest trends and insights prevalent in the recombinant DNA technology market, click the link below:https://www.coherentmarketinsights.com/market-insight/recombinant-dna-technology-market-893

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154
#3200

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Recombinant DNA Technology Market to Surpass US$ 196.7 Billion by 2026 here

News-ID: 1167177 • Views:

More Releases from CMI Research

Complete guide to Eosinophilic Esophagitis Market 2023: Expanding due to immune system rapid growth | Ellodi Pharmaceuticals, EsoCap AG, GlaxoSmithKline
Complete guide to Eosinophilic Esophagitis Market 2023: Expanding due to immune …
Eosinophilic Esophagitis (EoE) is a chronic inflammatory condition of the esophagus. It is characterized by the accumulation of a type of white blood cells called eosinophils in the lining of the esophagus. EoE can cause a range of symptoms, including difficulty swallowing, food impaction, chest pain, and heartburn. Steroids are the primary treatment option for EoE. They help control inflammation and reduce the number of eosinophils in the esophagus. Topical steroids
A complete guide to Adoptive Cell Therapy Market 2023: growing demand for personalized medicine rapid growth | Gilead Sciences, Inc., Castle Creek Biosciences, Inc., Lineage Cell Therapeutics
A complete guide to Adoptive Cell Therapy Market 2023: growing demand for person …
Adoptive cell therapy (ACT) is a form of immunotherapy that involves the genetic modification of T cells to enhance their cancer-fighting capabilities. This treatment has shown promising results in the treatment of several types of cancer and is expected to become a major player in the oncology market in the coming years. The global adoptive cell therapy market size was valued at USD 1.12 billion in 2021 and is projected to
A complete guide to the TCV Vaccines Market 2023: market size, growth trends, key drivers and and future outlook 2030 | GlaxoSmithKline PLC, Sanofi SA, Bharat Biotech
A complete guide to the TCV Vaccines Market 2023: market size, growth trends, ke …
Conjugate vaccine (Vi-TT) consists of Vi antigen that is coupled to a carrier protein. In this vaccine, polysaccharide is attached to a more complex protein. In infants, these cells can effectively develop immune protection against pathogens. Polysaccharides are weaker by itself, however, by binding to a protein carrier, polysaccharides can enter into important parts of the immune system with ease and can get more easily noticed by the immunity system
A complete guide to Corporate Wellness Market 2023: Market size, growth trends, key drivers and challenges, and future outlook 2030 | Wellness Corporate Solutions, ComPsych Corporation, United Health Group
A complete guide to Corporate Wellness Market 2023: Market size, growth trends, …
The corporate wellness market has been gaining popularity over the years as more companies recognize the importance of keeping their employees healthy and productive. Corporate wellness programs are designed to improve the overall health and well-being of employees by providing them with resources and support to manage their physical and mental health. The corporate wellness market is expected to grow significantly from 2023-2030. According to a report by Coherent Market Insights,

All 5 Releases


More Releases for DNA

High-Quality Plasmid DNA Fuels Growth in Global DNA Plasmid Manufacturing Market
🌍 Market Overview The DNA Plasmid Manufacturing Market is experiencing robust growth as advancements in cell & gene therapy, DNA vaccines, and genetic engineering continue to expand globally. Plasmid DNA plays a critical role as a raw material in the development of advanced therapies, fueling demand across biopharmaceutical research and production. Key factors driving the market include: Increasing adoption of gene and cell therapies Rising prevalence of chronic and rare genetic disorders Expansion of DNA-based
DNA Synthesis Market Increasing Demand for Synthetic Genes and DNA Sequences
As demonstrated by Precision Business Insights (PBI), the latest report, the global DNA synthesis market was valued at USD 3,702.0 million in 2023 and is expected to reach USD 10,289.5 million by 2029, growing at a CAGR of 18.6% during the forecast period 2024-2030. The key drivers for the growth of the global DNA synthesis market include increasing demand for synthetic genes and DNA sequences, growing applications in the agriculture
Wealth DNA Code Review Legit Price? (Wealth Manifestation DNA Code Audio Frequen …
Wealth DNA Code Wealth DNA Code is a digital program with seven minutes of soundtracks that manifest and listen to daily to activate the "Wealth DNA," which is part of your DNA to help you attract wealth by making money a part of your mentality and making your dreams to come true. https://bit.ly/Visit-The-Official-Website-Here-To-Order-Wealth-DNA-Code Making money, creating assets as well as increasing wealth are the primary objectives that every human being has to
DNA Paternity Testing Market Size [2022-2029] -DNA Diagnostics Center, EasyDNA, …
A recent market research report added to repository of MR Accuracy Reports is an in-depth analysis of global DNA Paternity Testing. On the basis of historic growth analysis and current scenario of DNA Paternity Testing place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent
DNA Paternity Testing Market Trends 2020 | Growth by Top Companies: DNA Diagnost …
The report begins with the overview of the DNA Paternity Testing Market and offers throughout development. It presents a comprehensive analysis of all the regional and major player segments that gives closer insights upon present market conditions and future market opportunities along with drivers, trending segments, consumer behaviour, pricing factors and market performance and estimation. The forecast market information, SWOT analysis, DNA Paternity Testing market scenario, and feasibility study are
DNA Paternity Testing Market Rapidly Growing in Healthcare, Competitor Analysis …
The exclusive research report on the Global DNA Paternity Testing Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global DNA Paternity Testing Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe. Overview of Global DNA Paternity Testing Market: This report studies the Global DNA Paternity Testing